Phase I study of neo-adjuvant chemoradiation therapy for newly diagnosed malignant astrocytomas
Phase 1
- Conditions
- malignant astyrocytomas
- Registration Number
- JPRN-UMIN000015566
- Lead Sponsor
- Chiba Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
large tumor (>6cm) sign of tent-herniation existence of extracranial malignant tumor pregnancy psychological disorder HIV positive patients history of pneumonitis history of radiation therapy for intracranial lesions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of adverse events until 12 weeks after treatment
- Secondary Outcome Measures
Name Time Method progression-free survival, overall survival